Skip to main content

Day: February 13, 2025

Neumora Therapeutics Announces Leadership Transition

Paul L. Berns, executive chair of Neumora Board of Directors, to serve as chief executive officer and chairman of the Board Joshua Pinto, Ph.D. to serve as president Bill Aurora, Pharm.D. to serve as chief operating and development officer; Michael Milligan to serve as chief financial officer Neumora to host conference call on March 3, 2025 to report its fourth quarter and full year 2024 financial results and provide a business update WATERTOWN, Mass., Feb. 13, 2025 (GLOBE NEWSWIRE) — Neumora Therapeutics, Inc. (Nasdaq: NMRA), a clinical-stage biopharmaceutical company with a therapeutics pipeline consisting of seven clinical and pre-clinical brain disease programs, today announced that effective February 14, 2025, Paul L. Berns, Neumora’s co-founder and executive chair of the Board of Directors, will transition to chief executive...

Continue reading

Mission Mobile Medical and REE Automotive Collaborate to Transport Healthcare to Millions of Rural Americans

Mission Mobile Medical and REE Automotive Partner to Transport Healthcare to Millions of Rural AmericansMission Mobile, the world’s largest mobile health company, intends to build its new mobile healthcare fleet on REE’s P7 electric trucksMission Mobile, one of the world’s largest mobile health companies, intends to build its new mobile healthcare fleet on REE’s P7 electric trucks. New Powered by REE fleet will aim to expand Mission Mobile’s 200 mobile healthcare programs targeting more than two million Americans in 42 states who currently do not have equitable healthcare access. First P7 vehicle delivery is slotted for mid 2025.GREENSBORO, N.C. and TEL AVIV, Israel, Feb. 13, 2025 (GLOBE NEWSWIRE) — Mission Mobile Medical and REE Automotive Ltd. (Nasdaq: REE) have signed an agreement under which REE will provide vehicles...

Continue reading

Cellebrite Announces Fourth-Quarter and Full-Year 2024 Results

Company delivers “Rule of 50” Performance in 2024 with 25% ARR growth and 25% adjusted EBITDA margin Fourth-quarter 2024 revenue of $109.0 million grew 17% primarily due to21% growth in subscription revenue ARR grew 25% to $395.9 million Fourth-quarter 2024 adjusted EBITDA of $28.8 million, 26.4% adjusted EBITDA margin TYSONS CORNER, Va. and PETAH TIKVA, Israel, Feb. 13, 2025 (GLOBE NEWSWIRE) — Cellebrite (NASDAQ: CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced financial results for the three and twelve months ending December 31, 2024. “Cellebrite delivered a solid fourth-quarter performance to cap an excellent 2024 in which we exceeded our original revenue and adjusted EBITDA targets and delivered at the higher end of our ARR expectations,” stated Thomas E....

Continue reading

Guardian Capital Announces February 2025 Cash Distributions for Guardian Capital ETFs

TORONTO, Feb. 13, 2025 (GLOBE NEWSWIRE) — Guardian Capital LP (the “Manager”) announces the following regular cash distributions for the period ending February 28, 2025, in respect of the ETF series of the Guardian Capital funds listed below (the “Guardian Capital ETFs”). In each case, the distribution will be paid on February 28, 2025 to unitholders of record on February 24, 2025. The ex-dividend date in each case is anticipated to be February 24, 2025.Guardian Capital ETFs Series of ETF Units DistributionFrequency TradingSymbol Exchange Distribution Amount(per ETF Unit)GuardBonds™ 2025 Investment Grade Bond Fund ETF Units Monthly GBFB Cboe Canada CAD$0.0269GuardBonds™ 2026 Investment Grade Bond Fund ETF Units Monthly GBFC Cboe Canada CAD$0.0258GuardBonds™ 2027 Investment Grade Bond Fund ETF Units Monthly GBFD Cboe...

Continue reading

Steve Madden Announces Definitive Agreement to Acquire Kurt Geiger

LONG ISLAND CITY, N.Y., Feb. 13, 2025 (GLOBE NEWSWIRE) — Steve Madden (Nasdaq: SHOO), a leading designer and marketer of fashion footwear, accessories and apparel, today announced that it has entered into a definitive agreement to acquire UK-based Kurt Geiger from a group led by international private equity firm Cinven for an enterprise value of approximately £289 million in cash. Edward Rosenfeld, Chairman and Chief Executive Officer of Steve Madden, commented, “With this acquisition, we are excited to add Kurt Geiger London, a brand that has exhibited exceptional growth over the last several years. Kurt Geiger London’s unique brand image, high-quality and statement-making styles and compelling value proposition have driven success across multiple product categories, led by handbags. Its differentiated and elevated positioning...

Continue reading

Brookfield Wealth Solutions Announces Year End 2024 Results and Declares Quarterly Distribution Increase

BROOKFIELD, NEWS, Feb. 13, 2025 (GLOBE NEWSWIRE) — Brookfield Wealth Solutions (NYSE, TSX: BNT) today announced financial results for the three months and year ended December 31, 2024. Sachin Shah, CEO of Brookfield Wealth Solutions, stated, “Our strong results for 2024 underscore our growth over the past year having doubled the size of the business in that time. Our scalable North American annuity platform, coupled with our leading investment capabilities, will serve as the foundation for our business as we expand internationally in 2025.”UnauditedAs of and for the periods ended December 31(US$ millions, except per share amounts) Three Months Ended   Year Ended  2024       2023       2024       2023  Total assets $ 140,460     $ 61,643     $ 140,460     $ 61,643  Adjusted equity1   12,872       8,969       12,872       8,969  Distributable...

Continue reading

Verona Pharma to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Corporate Update

LONDON and RALEIGH, N.C., Feb. 13, 2025 (GLOBE NEWSWIRE) — Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma” or the “Company”) announces that it will report its financial results for the fourth quarter and full year ended December 31, 2024 on Thursday, February 27, 2025 and host an investment community conference call at 9:00 a.m. EST / 2:00 p.m. GMT to discuss these financial results and provide a corporate update. To participate, please dial one of the following numbers and ask to join the Verona Pharma call:+1-800-836-8184 for callers in the United States +1-646-357-8785 for international callersA live webcast will be available on the Events and Presentations link on the Investors page of the Company’s website, www.veronapharma.com, and the audio replay will be available for 90 days. For further information please contact:Verona...

Continue reading

LXP Industrial Trust Reports Fourth Quarter 2024 Results

WEST PALM BEACH, Fla., Feb. 13, 2025 (GLOBE NEWSWIRE) — LXP Industrial Trust (“LXP”) (NYSE:LXP), a real estate investment trust focused on Class A warehouse and distribution real estate investments, today announced results for the quarter and year ended December 31, 2024. Fourth Quarter 2024 HighlightsRecorded Net Income attributable to common shareholders of $31.4 million, or $0.11 per diluted common share. Generated Adjusted Company Funds From Operations available to all equityholders – diluted (“Adjusted Company FFO”) of $47.0 million, or $0.16 per diluted common share. Increased Same-Store NOI 4.1% compared to the same period in 2023. Completed 1.0 million square feet of new leases and lease extensions, raising Base and Cash Base Rents by 66.3% and 42.6%, respectively, excluding a fixed-rate renewal. Acquired four...

Continue reading

Mullen Group Ltd. Announces 2024 Fourth Quarter Financial Results and Filing of Disclosure Documents

OKOTOKS, Alberta, Feb. 13, 2025 (GLOBE NEWSWIRE) — (TSX: MTL) Mullen Group Ltd. (“Mullen Group“, “We“, “Our” and/or the “Corporation“), one of Canada’s largest logistics providers today reported its financial and operating results for the quarter and year ended December 31, 2024, with comparisons to the same period last year. Full details of our financial and operating results may be found within our 2024 Annual Financial Review, which is available on the Corporation’s issuer profile on SEDAR+ at www.sedarplus.ca or on our website at www.mullen-group.com. “Looking at our financial performance in the fourth quarter, in fact for the entire year, you might conclude that not much was happening at the Mullen Group last year. But that was not the case at all. It took a...

Continue reading

TransUnion Collaborates with Credit Sesame to Launch New Freemium Direct-to-Consumer Credit Education and Monitoring Offering

Solution will engage more U.S. consumers to take action to manage their financial futures CHICAGO, Feb. 13, 2025 (GLOBE NEWSWIRE) — TransUnion (NYSE:TRU) has announced the launch of its new direct-to-consumer experience in the U.S., enabled by its strategic collaboration with Credit Sesame, a leader in the credit management space. This new offering is expected to enable TransUnion to more fully serve the tens of millions of consumers who visit TransUnion digital properties annually, with a highly engaging freemium credit education solution that will be integrated with enhanced premium credit monitoring services. This new experience will provide consumers with access to a suite of free credit education services, including a daily TransUnion credit score and report, in addition to optional premium credit monitoring services, available...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.